Literature DB >> 26339958

Clinical and histopathological outcomes in patients with SCN1A mutations undergoing surgery for epilepsy.

Karen L Skjei1,2, Ephraim W Church3, Brian N Harding1,2, Mariarita Santi1,2, Katherine D Holland-Bouley4, Robert R Clancy1,2, Brenda E Porter1,2, Gregory G Heuer1,2, Eric D Marsh1,2.   

Abstract

OBJECT: Mutations in the sodium channel alpha 1 subunit gene (SCN1A) have been associated with a wide range of epilepsy phenotypes including Dravet syndrome. There currently exist few histopathological and surgical outcome reports in patients with this disease. In this case series, the authors describe the clinical features, surgical pathology, and outcomes in 6 patients with SCN1A mutations and refractory epilepsy who underwent focal cortical resection prior to uncovering the genetic basis of their epilepsy.
METHODS: Medical records of SCN1A mutation-positive children with treatment-resistant epilepsy who had undergone resective epilepsy surgery were reviewed retrospectively. Surgical pathology specimens were reviewed.
RESULTS: All 6 patients identified carried diagnoses of intractable epilepsy with mixed seizure types. Age at surgery ranged from 18 months to 20 years. Seizures were refractory to surgery in every case. Surgical histopathology showed evidence of subtle cortical dysplasia in 4 of 6 patients, with more neurons in the molecular layer of the cortex and white matter.
CONCLUSIONS: Cortical resection is unlikely to be beneficial in these children due to the genetic defect and the unexpected neuropathological finding of mild diffuse malformations of cortical development. Together, these findings suggest a diffuse pathophysiological mechanism of the patients' epilepsy which will not respond to focal resective surgery.

Entities:  

Keywords:  Dravet syndrome; EEG = electroencephalography; GEFS+ = generalized epilepsy with febrile seizures plus; ILAE = International League Against Epilepsy; MCD = malformation of cortical development; MTS = mesial temporal sclerosis; SCN1A mutations; SMEI = severe myoclonic epilepsy of infancy; cortical malformations; epilepsy surgery; histopathology

Mesh:

Substances:

Year:  2015        PMID: 26339958     DOI: 10.3171/2015.5.PEDS14551

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  10 in total

1.  Histopathology of ~10,000 (Yes, That's TEN THOUSAND) Brain Tissue Samples From Epilepsy Surgery.

Authors:  Jong Woo Lee
Journal:  Epilepsy Curr       Date:  2018 Mar-Apr       Impact factor: 7.500

Review 2.  [Epilepsy-new diagnostic tools, old drugs? : Therapeutic consequences of epilepsy genetics].

Authors:  M Tacke; B A Neubauer; L Gerstl; T Roser; J Rémi; I Borggraefe
Journal:  Nervenarzt       Date:  2017-12       Impact factor: 1.214

3.  Epilepsy surgery in PCDH 19 related developmental and epileptic encephalopathy: A case report.

Authors:  Lakshmi Nagarajan; Soumya Ghosh; Jason Dyke; Sharon Lee; Jonathan Silberstein; Dimitar Azmanov; Warne Richard
Journal:  Epilepsy Behav Rep       Date:  2022-07-06

Review 4.  Palliative epilepsy surgery in Dravet syndrome-case series and review of the literature.

Authors:  Brian J Dlouhy; Brandon Miller; Anna Jeong; Mary E Bertrand; David D Limbrick; Matthew D Smyth
Journal:  Childs Nerv Syst       Date:  2016-07-27       Impact factor: 1.475

5.  Dravet syndrome and Dravet syndrome-like phenotype: a systematic review of the SCN1A and PCDH19 variants.

Authors:  Ana Carla Mondek Rampazzo; Rafael Rodrigues Pinheiro Dos Santos; Fernando Arfux Maluf; Renata Faria Simm; Fernando Augusto Lima Marson; Manoela Marques Ortega; Paulo Henrique Pires de Aguiar
Journal:  Neurogenetics       Date:  2021-05-03       Impact factor: 2.660

6.  Vagus nerve stimulation for genetic epilepsy with febrile seizures plus (GEFS+) accompanying seizures with impaired consciousness.

Authors:  Ryosuke Hanaya; Fajar H Niantiarno; Yumi Kashida; Hiroshi Hosoyama; Shinsuke Maruyama; Toshiaki Otsubo; Kazumi Tanaka; Atsushi Ishii; Shinichi Hirose; Kazunori Arita
Journal:  Epilepsy Behav Case Rep       Date:  2016-11-09

7.  Genetic characteristics of non-familial epilepsy.

Authors:  Kyung Wook Kang; Wonkuk Kim; Yong Won Cho; Sang Kun Lee; Ki-Young Jung; Wonchul Shin; Dong Wook Kim; Won-Joo Kim; Hyang Woon Lee; Woojun Kim; Keuntae Kim; So-Hyun Lee; Seok-Yong Choi; Myeong-Kyu Kim
Journal:  PeerJ       Date:  2019-12-19       Impact factor: 2.984

Review 8.  A review of fenfluramine for the treatment of Dravet syndrome patients.

Authors:  Kayla Simon; Hunter Sheckley; Christopher L Anderson; Zhao Liu; Paul R Carney
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-12-16

9.  Epilepsy surgery in patient with monogenic epilepsy related to SCN8A mutation.

Authors:  Irina Podkorytova; Ryan Hays; Ghazala Perven; Sasha Alick Lindstrom
Journal:  Epilepsy Behav Rep       Date:  2022-03-22

10.  The ILAE consensus classification of focal cortical dysplasia: An update proposed by an ad hoc task force of the ILAE diagnostic methods commission.

Authors:  Imad Najm; Dennis Lal; Mario Alonso Vanegas; Fernando Cendes; Iscia Lopes-Cendes; Andre Palmini; Eliseu Paglioli; Harvey B Sarnat; Christopher A Walsh; Samuel Wiebe; Eleonora Aronica; Stéphanie Baulac; Roland Coras; Katja Kobow; J Helen Cross; Rita Garbelli; Hans Holthausen; Karl Rössler; Maria Thom; Assam El-Osta; Jeong Ho Lee; Hajime Miyata; Renzo Guerrini; Yue-Shan Piao; Dong Zhou; Ingmar Blümcke
Journal:  Epilepsia       Date:  2022-06-15       Impact factor: 6.740

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.